Citation Impact
Citing Papers
Quantitative analysis of sponsorship bias in economic studies of antidepressants
2003
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
2013
Can discrete event simulation be of use in modelling major depression?
2006
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing
2018 Standout
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
A review of economic impact of targeted oral anticancer medications
2013
Assessing Quality in Decision Analytic Cost-Effectiveness Models
2000
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability
2005
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review
2010
Perioperative Management of Antithrombotic Therapy
2012 Standout
A Feasibility Study of Transdermal Buprenorphine Versus Transdermal Fentanyl in the Long-Term Management of Persistent Non-Cancer Pain
2013
Antithrombotic Therapy for VTE Disease
2016 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Outcomes of early switching from intravenous to oral antibiotics on medical wards
2009
Psoriasis
2021 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis
2017
Antithrombotic Therapy for VTE Disease
2012 Standout
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in the hospital setting
2015
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Executive Summary
2012 Standout
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
2010 Standout
Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis
2005
A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries
2014
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Prevention of Venous Thromboembolism
2004 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Etanercept
2002
Rheumatoid arthritis
2010 Standout
Psoriasis
2003
Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data
2007
Prevention of Venous Thromboembolism
2008 Standout
Epidemiology of stone disease across the world
2017 Standout
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis
2011
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost‐effectiveness analysis
2007
Levodopa/carbidopa/entacapone in Parkinson’s disease
2009
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive Pathogens
2005
Topical Analgesics in the Management of Acute and Chronic Pain
2013
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
2003 Standout
ESPEN expert group recommendations for action against cancer-related malnutrition
2017
The pros, cons, and many unknowns of probiotics
2019 Standout
The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care — an observational analysis on non-small-cell lung cancer patients
2013
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
The perceived effectiveness regarding Immersive Virtual Reality learning environments changes by the prior knowledge of learners
2020 Standout
Immunology of Psoriasis
2014 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Neuropathic Pain
2009
Comparing the Costs, Risks, and Benefits of Competing Strategies for the Primary Prevention of Venous Thromboembolism
2004
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease
2007
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients
2007
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study
2009
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
2004
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Generalisability in economic evaluation studies in healthcare: a review and case studies
2004
Hematological findings and complications of COVID ‐19
2020 Standout
Industry sponsorship and research outcome
2017 Standout
Works of Mark Nuijten being referenced
Cost effectiveness of palivizumab in Spain: an analysis using observational data
2009
Cost Effectiveness of Treatment of Parkinson??s Disease with Entacapone in the United States
2002
Applications of Modelling Studies
1998
Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries
2001
Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria
2008
A Markov Process Analysis Comparing the Cost Effectiveness of Maintenance Therapy with Citalopram versus Standard Therapy in Major Depression
1995
A Cost-Cost Study Comparing Etanercept with Infliximab in Rheumatoid Arthritis
2001
Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria
2011
Cost effectiveness of palivizumab in children with congenital heart disease in Germany
2009
A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer
2011
Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France
1998
Economic Evaluation of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in Canada
2000
Cost-Effectiveness Analysis of a Lidocaine 5% Medicated Plaster Compared with Gabapentin and Pregabalin for Treating Postherpetic Neuralgia
2008
Importance of nondrug costs of intravenous antibiotic therapy
2003
Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany
2010
Cost Effectiveness of a Lidocaine 5% Medicated Plaster Compared with Pregabalin for the Treatment of Postherpetic Neuralgia in the UK
2010
Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands
2009
Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process Analysis
2002
The economic costs of disease related malnutrition
2012
Health economic analyses in medical nutrition: a systematic literature review
2014
Cost-Effectiveness Analysis of Entacapone in Parkinson's Disease: A Markov Process Analysis
2001
Workshop Report: concepts and methods in the economics of nutrition – gateways to better economic evaluation of nutrition interventions
2012
Cost-Effectiveness of Enoxaparin as Thromboprophylaxis in Acutely Ill Medical Patients in Spain
2003
Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children
2007
Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK
1999
Cost-Effectiveness of a Lidocaine 5% Medicated Plaster Relative to Gabapentin for Postherpetic Neuralgia in the United Kingdom
2007
Patterns of Dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: A retrospective data analysis in Germany
2006
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib
2009
Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
2014
Increased Water Intake as a Prevention Strategy for Recurrent Urolithiasis: Major Impact of Compliance on Cost-Effectiveness
2012
PHP107 THE HEALTH ECONOMIC IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN THE HOSPITAL SETTING IN GERMANY
2010
Cost-effectiveness of enoxaparin as thromboprophylaxis in acutelly ill medical patients from the Italian NHS perspective.
2002
Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective
2009